#United States #New York #SueWallSt #Park Ha #BYAH

Investors with Losses in Park Ha Biological Technology Explore Class Action Legal Options

In a significant event for investors, a class action lawsuit related to Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) is drawing attention as shareholders seek legal recourse for the massive losses incurred following the company's stock volatility. The situation unfolded between December 2024 and July 2025, when shares of Park Ha soared from an initial offering price of $4.00 to a staggering peak of $41.49 before experiencing a catastrophic drop of 93% to $2.99 per share in a single session on July 8, 2025.

This dramatic decline has wiped out more than $1 billion in market value, prompting affected investors to consider their options for recovery. SueWallSt encourages those who invested in Park Ha securities during the period of December 27, 2024, to July 8, 2025, to come forward and explore their eligibility for compensation from potential damages incurred.

Timeline of Events

The trajectory of Park Ha Biological Technology's shares showcases a stark contrast between inflated market enthusiasm and subsequent declines without substantial corporate disclosures. Here’s a quick look at the pivotal events leading to the investor turmoil:

• - December 27, 2024: The company conducts an IPO, offering 1.2 million shares at $4.00, raising approximately $4.8 million.
• - December 30, 2024: Park Ha shares begin trading on the Nasdaq, initially showing moderate interest.
• - June 2025: The stock begins an extraordinary rise, partly attributed to undisclosed promotions and an increasing daily trading volume, reaching a peak of over $41 by early July.
• - July 8, 2025: Abruptly, shares crash to $2.99 without any announced corporate developments or explanations, marking a severe market reaction.
• - Once a darling of the market, the shares' fall raised pressing questions regarding transparency and possible market manipulation.

The Legal Response

With the September 28, 2026 deadline approaching for investors interested in becoming lead plaintiffs, SueWallSt is actively gathering contact information from affected shareholders. Individuals who made purchases during the class period and faced losses are encouraged to step forward to ensure their voices are represented.

Joseph E. Levi, Esq., leading this legal initiative, stated, "Timely disclosure of material developments is fundamental to fair and efficient markets. Our complaint highlights the steep rise in Park Ha's stock price without any corresponding corporate announcements, leading to a crucial failure in communication with shareholders when the collapse occurred."

In the wake of this decline, generate interest has surged regarding the potential consequences of the alleged promotional tactics utilized by those behind the shares. Despite previous market euphoria, the aftermath reveals a somber reality for investors who now face the prospect of litigation to recoup their losses.

FAQs for Concerned Investors

If you’re wondering about your eligibility to participate in this lawsuit or seeking specific legal guidance, here are some common queries:

• - What defines a lead plaintiff?: The lead plaintiff is appointed by a court to represent the entire class, typically someone with the largest documented losses.
• - Can I participate if I sold my shares?: Yes, eligibility is based on purchasing dates, not the current holding status.
• - Are there costs involved in joining the lawsuit?: Generally, there are no upfront costs; securities class actions often operate on a contingency basis, allowing investors to pursue potential recovery with no out-of-pocket expense.

This growing legal initiative is pivotal not just for recovery but also for fostering accountability among publicly traded companies. Investors facing significant losses in the Park Ha Biological Technology saga may need to act swiftly to engage in meaningful collective action.